Building Biomimetic Potency Tests for Islet Transplantation.

Area of Science:

• Endocrinology
• Regenerative Medicine
• Biomedical Engineering

Background:

• Diabetes mellitus necessitates insulin therapy, often exogenous insulin, due to insulin insufficiency.
• Islet transplantation offers insulin independence but faces limitations in cell availability and functional assessment.
• Stem cell advancements promise more cells, yet predictive outcome tests remain underdeveloped.

Purpose of the Study:

• To propose next-generation islet potency tests that are biomimetic.
• To enhance the prediction of islet transplantation outcomes.
• To improve the assessment of islet function and quality.

Main Methods:

• Reviewing current islet potency testing approaches.
• Outlining technologies for biomimetic systems.
• Focusing on systems that mimic glucose dynamics and microenvironment.
• Assessing conditional and continuous insulin secretion.

Main Results:

• Current potency tests lack predictive power for transplantation outcomes.
• Biomimetic systems offer a path toward more accurate islet function assessment.
• Minimal manual handling and rapid assessment are key features.

Conclusions:

• Biomimetic islet potency tests are essential for advancing islet transplantation.
• Improved potency testing will increase the reliability and accessibility of diabetes treatment.
• These tests will track islet secretory capacity in a relevant functional context.